ClinicalTrials.govpublic full text
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
arthritis, rheumatoid, rheumatoid arthritis, anti-tnfa agents, subcutaneous injection, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877264
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.